Description:

CALGB: 80405 TREATMENT AND RESPONSE FORM NCT00265850 Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F39D6C01-851A-64CF-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F39D6C01-851A-64CF-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/27/12
  2. 1/9/15
  3. 6/9/15
Uploaded on:

June 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

CALGB: 80405 TREATMENT AND RESPONSE FORM NCT00265850

INSTRUCTIONS: Complete and submit this form as required by the protocol. Information in the upper right box must be completed for this form to be accepted.

Header
Are data amended
Patient demographics
Assessment of Chemotherapy
Agent name
Lab results
mmol/L
Did the patient receive calcium or magnesium infusions during this reporting period?
Off-protocol treatment
Off treatment reason (if applicable Mark one with an X.)
Alternative therapy, specify
Weeks 1 And 2
Dose level received (^1)
Dose modification reason (^2)
Weeks 3 And 4
Weeks 5 And 6
Weeks 7 And 8
Survival Date
Vital Status
Primary Cause of Death
Response Data
Response at this assessment
Sites of progression (for pre-surgical or surgical response Mark all that apply with an X.)

Similar models